| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d8005add991c5761db7d398b7be3e11b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7da5c8e8c3e8261efe7e698c7198681b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-8132
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-711
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6459 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-711
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-81 |
| filingDate |
2002-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d43a7383308d029a519ee974b8ec50e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cff92f69fd1147c047b80304985d552a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f224551a44bd27df78185e92224d8f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f4f7bbadb746d18ac97919c46374141 |
| publicationDate |
2007-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2268921-A1 |
| titleOfInvention |
THERAPEUTIC COMPOSITION FOR THE TREATMENT OF TUMORS AND ITS APPLICATIONS. |
| abstract |
Therapeutic composition for the treatment ofnTumors and their applications.n n n The tissue plasminogen activatorn(t-PA) is a serine protease overexpressed innvarious types of tumors, including pancreatic cancer, melanomas andnneuroblastomas The present invention consists of a processnto inhibit protein expression and activitynt-PA involved in human tumors consisting ofntherapeutic compositions containing inhibitors ofnt-PA protein expression and activity. |
| priorityDate |
2002-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |